Atlas Trials

A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

Clinical trial NCT06729320 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06729320
Sponsor
Beijing GoBroad Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Refractory Immune Effector Cell-related Hemocytopenia
Start date
2024-12-01
Primary completion
2025-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.